Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)

N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO). The crystal structure of human FTO with 1a reveals a novel binding site for the FTO inhibitor and defines the molecular basis for recognitio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2015-09, Vol.58 (18), p.7341-7348
Hauptverfasser: He, Wu, Zhou, Bin, Liu, Weijia, Zhang, Meizi, Shen, Zhenhua, Han, Zhifu, Jiang, Qingwei, Yang, Qinghua, Song, Chuanjun, Wang, Ruiyong, Niu, Tianhui, Han, Shengna, Zhang, Lirong, Wu, Jie, Guo, Feima, Zhao, Renbin, Yu, Wenquan, Chai, Jijie, Chang, Junbiao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7348
container_issue 18
container_start_page 7341
container_title Journal of medicinal chemistry
container_volume 58
creator He, Wu
Zhou, Bin
Liu, Weijia
Zhang, Meizi
Shen, Zhenhua
Han, Zhifu
Jiang, Qingwei
Yang, Qinghua
Song, Chuanjun
Wang, Ruiyong
Niu, Tianhui
Han, Shengna
Zhang, Lirong
Wu, Jie
Guo, Feima
Zhao, Renbin
Yu, Wenquan
Chai, Jijie
Chang, Junbiao
description N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO). The crystal structure of human FTO with 1a reveals a novel binding site for the FTO inhibitor and defines the molecular basis for recognition by FTO of the inhibitor. The identification of the new binding site offers new opportunities for further development of selective and potent inhibitors of FTO, which is expected to provide information concerning novel therapeutic targets for treatment of obesity or obesity-associated diseases.
doi_str_mv 10.1021/acs.jmedchem.5b00702
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1716937854</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1716937854</sourcerecordid><originalsourceid>FETCH-LOGICAL-a414t-7fc7d8c8f99fbb1c92e1a4af886ee9ee64cf700b027218663fc6096c3599a8453</originalsourceid><addsrcrecordid>eNp9kE1P20AQhleoiITQf1BVe6QHh9kPr73HFDUtEhAk6Nlar2fLRraXetdI-fd1SOiR0xzmed_RPIR8YbBkwNmVsXG57bCxz9gt8xqgAH5C5iznkMkS5CcyB-A844qLGTmPcQsAgnFxRmZcCSaF0HOyvWmwT955a5IPPQ2Oruh9eMWWPnambbO70KIdW6Tffd_4_g999An3WHpGujaJ3pkYqekbuqkx-rSjqxiD9SZhQx-GkND39HL9tPl2QU6daSN-Ps4F-b3-8XT9K7vd_Ly5Xt1mRjKZssLZoilt6bR2dc2s5siMNK4sFaJGVNK6AqAGXnBWKiWcVaCVFbnWppS5WJDLQ-_LEP6OGFPV-WixbU2PYYwVK5jSoihzOaHygNohxDigq14G35lhVzGo9paryXL1brk6Wp5iX48Xxnra_Q-9a50AOABv8TAO_fTwx53_AMyAiwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1716937854</pqid></control><display><type>article</type><title>Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)</title><source>ACS Publications</source><source>MEDLINE</source><creator>He, Wu ; Zhou, Bin ; Liu, Weijia ; Zhang, Meizi ; Shen, Zhenhua ; Han, Zhifu ; Jiang, Qingwei ; Yang, Qinghua ; Song, Chuanjun ; Wang, Ruiyong ; Niu, Tianhui ; Han, Shengna ; Zhang, Lirong ; Wu, Jie ; Guo, Feima ; Zhao, Renbin ; Yu, Wenquan ; Chai, Jijie ; Chang, Junbiao</creator><creatorcontrib>He, Wu ; Zhou, Bin ; Liu, Weijia ; Zhang, Meizi ; Shen, Zhenhua ; Han, Zhifu ; Jiang, Qingwei ; Yang, Qinghua ; Song, Chuanjun ; Wang, Ruiyong ; Niu, Tianhui ; Han, Shengna ; Zhang, Lirong ; Wu, Jie ; Guo, Feima ; Zhao, Renbin ; Yu, Wenquan ; Chai, Jijie ; Chang, Junbiao</creatorcontrib><description>N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO). The crystal structure of human FTO with 1a reveals a novel binding site for the FTO inhibitor and defines the molecular basis for recognition by FTO of the inhibitor. The identification of the new binding site offers new opportunities for further development of selective and potent inhibitors of FTO, which is expected to provide information concerning novel therapeutic targets for treatment of obesity or obesity-associated diseases.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.5b00702</identifier><identifier>PMID: 26314339</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>3T3-L1 Cells ; Alpha-Ketoglutarate-Dependent Dioxygenase FTO ; Aminophenols - chemical synthesis ; Aminophenols - chemistry ; Aminophenols - pharmacology ; Anilides - chemical synthesis ; Anilides - chemistry ; Anilides - pharmacology ; Animals ; Binding Sites ; Crystallography, X-Ray ; Databases, Chemical ; Humans ; Methylation ; Mice ; Models, Molecular ; Protein Binding ; Proteins - antagonists &amp; inhibitors ; Proteins - chemistry ; RNA - chemistry ; RNA, Messenger - metabolism</subject><ispartof>Journal of medicinal chemistry, 2015-09, Vol.58 (18), p.7341-7348</ispartof><rights>Copyright © 2015 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a414t-7fc7d8c8f99fbb1c92e1a4af886ee9ee64cf700b027218663fc6096c3599a8453</citedby><cites>FETCH-LOGICAL-a414t-7fc7d8c8f99fbb1c92e1a4af886ee9ee64cf700b027218663fc6096c3599a8453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00702$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00702$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26314339$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Wu</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>Liu, Weijia</creatorcontrib><creatorcontrib>Zhang, Meizi</creatorcontrib><creatorcontrib>Shen, Zhenhua</creatorcontrib><creatorcontrib>Han, Zhifu</creatorcontrib><creatorcontrib>Jiang, Qingwei</creatorcontrib><creatorcontrib>Yang, Qinghua</creatorcontrib><creatorcontrib>Song, Chuanjun</creatorcontrib><creatorcontrib>Wang, Ruiyong</creatorcontrib><creatorcontrib>Niu, Tianhui</creatorcontrib><creatorcontrib>Han, Shengna</creatorcontrib><creatorcontrib>Zhang, Lirong</creatorcontrib><creatorcontrib>Wu, Jie</creatorcontrib><creatorcontrib>Guo, Feima</creatorcontrib><creatorcontrib>Zhao, Renbin</creatorcontrib><creatorcontrib>Yu, Wenquan</creatorcontrib><creatorcontrib>Chai, Jijie</creatorcontrib><creatorcontrib>Chang, Junbiao</creatorcontrib><title>Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO). The crystal structure of human FTO with 1a reveals a novel binding site for the FTO inhibitor and defines the molecular basis for recognition by FTO of the inhibitor. The identification of the new binding site offers new opportunities for further development of selective and potent inhibitors of FTO, which is expected to provide information concerning novel therapeutic targets for treatment of obesity or obesity-associated diseases.</description><subject>3T3-L1 Cells</subject><subject>Alpha-Ketoglutarate-Dependent Dioxygenase FTO</subject><subject>Aminophenols - chemical synthesis</subject><subject>Aminophenols - chemistry</subject><subject>Aminophenols - pharmacology</subject><subject>Anilides - chemical synthesis</subject><subject>Anilides - chemistry</subject><subject>Anilides - pharmacology</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Crystallography, X-Ray</subject><subject>Databases, Chemical</subject><subject>Humans</subject><subject>Methylation</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Protein Binding</subject><subject>Proteins - antagonists &amp; inhibitors</subject><subject>Proteins - chemistry</subject><subject>RNA - chemistry</subject><subject>RNA, Messenger - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1P20AQhleoiITQf1BVe6QHh9kPr73HFDUtEhAk6Nlar2fLRraXetdI-fd1SOiR0xzmed_RPIR8YbBkwNmVsXG57bCxz9gt8xqgAH5C5iznkMkS5CcyB-A844qLGTmPcQsAgnFxRmZcCSaF0HOyvWmwT955a5IPPQ2Oruh9eMWWPnambbO70KIdW6Tffd_4_g999An3WHpGujaJ3pkYqekbuqkx-rSjqxiD9SZhQx-GkND39HL9tPl2QU6daSN-Ps4F-b3-8XT9K7vd_Ly5Xt1mRjKZssLZoilt6bR2dc2s5siMNK4sFaJGVNK6AqAGXnBWKiWcVaCVFbnWppS5WJDLQ-_LEP6OGFPV-WixbU2PYYwVK5jSoihzOaHygNohxDigq14G35lhVzGo9paryXL1brk6Wp5iX48Xxnra_Q-9a50AOABv8TAO_fTwx53_AMyAiwg</recordid><startdate>20150924</startdate><enddate>20150924</enddate><creator>He, Wu</creator><creator>Zhou, Bin</creator><creator>Liu, Weijia</creator><creator>Zhang, Meizi</creator><creator>Shen, Zhenhua</creator><creator>Han, Zhifu</creator><creator>Jiang, Qingwei</creator><creator>Yang, Qinghua</creator><creator>Song, Chuanjun</creator><creator>Wang, Ruiyong</creator><creator>Niu, Tianhui</creator><creator>Han, Shengna</creator><creator>Zhang, Lirong</creator><creator>Wu, Jie</creator><creator>Guo, Feima</creator><creator>Zhao, Renbin</creator><creator>Yu, Wenquan</creator><creator>Chai, Jijie</creator><creator>Chang, Junbiao</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150924</creationdate><title>Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)</title><author>He, Wu ; Zhou, Bin ; Liu, Weijia ; Zhang, Meizi ; Shen, Zhenhua ; Han, Zhifu ; Jiang, Qingwei ; Yang, Qinghua ; Song, Chuanjun ; Wang, Ruiyong ; Niu, Tianhui ; Han, Shengna ; Zhang, Lirong ; Wu, Jie ; Guo, Feima ; Zhao, Renbin ; Yu, Wenquan ; Chai, Jijie ; Chang, Junbiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a414t-7fc7d8c8f99fbb1c92e1a4af886ee9ee64cf700b027218663fc6096c3599a8453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>3T3-L1 Cells</topic><topic>Alpha-Ketoglutarate-Dependent Dioxygenase FTO</topic><topic>Aminophenols - chemical synthesis</topic><topic>Aminophenols - chemistry</topic><topic>Aminophenols - pharmacology</topic><topic>Anilides - chemical synthesis</topic><topic>Anilides - chemistry</topic><topic>Anilides - pharmacology</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Crystallography, X-Ray</topic><topic>Databases, Chemical</topic><topic>Humans</topic><topic>Methylation</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Protein Binding</topic><topic>Proteins - antagonists &amp; inhibitors</topic><topic>Proteins - chemistry</topic><topic>RNA - chemistry</topic><topic>RNA, Messenger - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Wu</creatorcontrib><creatorcontrib>Zhou, Bin</creatorcontrib><creatorcontrib>Liu, Weijia</creatorcontrib><creatorcontrib>Zhang, Meizi</creatorcontrib><creatorcontrib>Shen, Zhenhua</creatorcontrib><creatorcontrib>Han, Zhifu</creatorcontrib><creatorcontrib>Jiang, Qingwei</creatorcontrib><creatorcontrib>Yang, Qinghua</creatorcontrib><creatorcontrib>Song, Chuanjun</creatorcontrib><creatorcontrib>Wang, Ruiyong</creatorcontrib><creatorcontrib>Niu, Tianhui</creatorcontrib><creatorcontrib>Han, Shengna</creatorcontrib><creatorcontrib>Zhang, Lirong</creatorcontrib><creatorcontrib>Wu, Jie</creatorcontrib><creatorcontrib>Guo, Feima</creatorcontrib><creatorcontrib>Zhao, Renbin</creatorcontrib><creatorcontrib>Yu, Wenquan</creatorcontrib><creatorcontrib>Chai, Jijie</creatorcontrib><creatorcontrib>Chang, Junbiao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Wu</au><au>Zhou, Bin</au><au>Liu, Weijia</au><au>Zhang, Meizi</au><au>Shen, Zhenhua</au><au>Han, Zhifu</au><au>Jiang, Qingwei</au><au>Yang, Qinghua</au><au>Song, Chuanjun</au><au>Wang, Ruiyong</au><au>Niu, Tianhui</au><au>Han, Shengna</au><au>Zhang, Lirong</au><au>Wu, Jie</au><au>Guo, Feima</au><au>Zhao, Renbin</au><au>Yu, Wenquan</au><au>Chai, Jijie</au><au>Chang, Junbiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2015-09-24</date><risdate>2015</risdate><volume>58</volume><issue>18</issue><spage>7341</spage><epage>7348</epage><pages>7341-7348</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide (N-CDPCB, 1a) is found to be an inhibitor of the fat mass and obesity associated protein (FTO). The crystal structure of human FTO with 1a reveals a novel binding site for the FTO inhibitor and defines the molecular basis for recognition by FTO of the inhibitor. The identification of the new binding site offers new opportunities for further development of selective and potent inhibitors of FTO, which is expected to provide information concerning novel therapeutic targets for treatment of obesity or obesity-associated diseases.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>26314339</pmid><doi>10.1021/acs.jmedchem.5b00702</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2015-09, Vol.58 (18), p.7341-7348
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_1716937854
source ACS Publications; MEDLINE
subjects 3T3-L1 Cells
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Aminophenols - chemical synthesis
Aminophenols - chemistry
Aminophenols - pharmacology
Anilides - chemical synthesis
Anilides - chemistry
Anilides - pharmacology
Animals
Binding Sites
Crystallography, X-Ray
Databases, Chemical
Humans
Methylation
Mice
Models, Molecular
Protein Binding
Proteins - antagonists & inhibitors
Proteins - chemistry
RNA - chemistry
RNA, Messenger - metabolism
title Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A54%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20A%20Novel%20Small-Molecule%20Binding%20Site%20of%20the%20Fat%20Mass%20and%20Obesity%20Associated%20Protein%20(FTO)&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=He,%20Wu&rft.date=2015-09-24&rft.volume=58&rft.issue=18&rft.spage=7341&rft.epage=7348&rft.pages=7341-7348&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.5b00702&rft_dat=%3Cproquest_cross%3E1716937854%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1716937854&rft_id=info:pmid/26314339&rfr_iscdi=true